Search Results - "Peddi, V. R."
-
1
-
2
Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus
Published in American journal of transplantation (01-09-2017)“…A key objective in the use of immunosuppression after kidney transplantation is to attain the optimal balance between efficacy and safety. In a phase 3b,…”
Get full text
Journal Article -
3
Efficacy and Safety of Everolimus Plus Low‐Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard‐Dose Tacrolimus in De Novo Renal Transplant Recipients: 12‐Month Data
Published in American journal of transplantation (01-05-2017)“…In this 12‐month, multicenter, randomized, open‐label, noninferiority study, de novo renal transplant recipients (RTxRs) were randomized (1:1) to receive…”
Get full text
Journal Article -
4
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function
Published in Transplantation proceedings (01-04-2019)“…TruGraf v1 is a laboratory-developed DNA microarray-based gene expression blood test to enable proactive noninvasive serial assessment of kidney transplant…”
Get full text
Journal Article -
5
Calcineurin‐Inhibitor‐Free Immunosuppression Based on the JAK Inhibitor CP‐690,550: A Pilot Study in De Novo Kidney Allograft Recipients
Published in American journal of transplantation (01-08-2009)“…This randomized, pilot study compared the Janus kinase inhibitor CP‐690,550 (15 mg BID [CP15] and 30 mg BID [CP30], n = 20 each) with tacrolimus (n = 21) in de…”
Get full text
Journal Article -
6
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice
Published in Transplantation proceedings (01-04-2019)“…TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant…”
Get full text
Journal Article -
7
Polyomavirus in kidney and kidney–pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring
Published in Transplantation proceedings (01-08-2002)Get full text
Journal Article Conference Proceeding -
8
Malignancies complicating organ transplantation
Published in Transplantation proceedings (01-09-1998)Get full text
Journal Article Conference Proceeding -
9
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature
Published in Transplantation (27-01-2003)“…Mucosa-associated lymphoid tissue lymphoma (MALToma) is a Helicobacter pylori-related tumor of B-cell origin, the malignant potential for which remains to be…”
Get full text
Journal Article -
10
HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival
Published in Transplantation proceedings (01-11-2001)Get full text
Journal Article -
11
Proteinuria following renal transplantation: Correlation with histopathology and outcome
Published in Transplantation proceedings (01-02-1997)Get full text
Journal Article Conference Proceeding -
12
Control of risk factors for cardiovascular disease in long-term renal transplant recipients
Published in Transplantation proceedings (01-11-2001)Get full text
Journal Article -
13
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus
Published in Transplantation proceedings (01-12-1998)Get full text
Journal Article Conference Proceeding -
14
Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients
Published in Clinical transplantation (01-02-1996)“…Neutropenia in solid organ transplant recipients may be caused by immunosuppressive therapy, antimicrobial therapy, as well as bacterial and viral infections…”
Get more information
Journal Article -
15
Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation
Published in Transplantation proceedings (01-02-1999)Get full text
Journal Article Conference Proceeding -
16
Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry
Published in Transplantation proceedings (01-02-1999)Get full text
Journal Article Conference Proceeding -
17
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation
Published in Transplantation proceedings (01-02-1997)Get full text
Journal Article Conference Proceeding -
18
Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method
Published in Transplantation proceedings (01-12-1998)Get full text
Journal Article Conference Proceeding -
19
Graft outcome in patients with biopsy-proven chronic renal allograft rejection
Published in Transplantation proceedings (01-02-1999)Get full text
Journal Article Conference Proceeding -
20
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients
Published in Transplantation (15-05-2002)“…In view of the superior T-cell depletion and prolonged half-life of thymoglobulin, we initiated a protocol to administer thymoglobulin intermittently based on…”
Get full text
Journal Article